Faculty

Institution

Unit

Venue

John Mendelsohn

Director

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Cancer Medicine

Department Of Palliative, Rehabilitation And Integrative Medicine

Department Of Neurosurgery

Department Of Pathology And Genomic Medicine

Department Of Thoracic-Head And Neck Medical Oncology

Division Of Cancer Medicine

The University of Texas MD Anderson Cancer Center

John Mendelsohn is currently serving as a Breast Surgical Oncology Director at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

John Mendelsohn

The University of Texas MD Anderson Cancer Center

Director

You can click a keyword to filter the displayed items

cell biology immunology cancer cells oncogenes cancer research tumor biology oncology therapeutic targets pharmacology cancer biology medicinal research molecular cancer tumor targeting cancer growth cell signaling breast cancer cancer immunotherapy cell growth cancer treatment pathology signal transduction cellular therapy cancer discovery cell research cell proliferation receptor tyrosine kinases antibody engineering anti-cancer agents cancer genomics cellular physiology cancer care breast oncology molecular cell biology cell death leukemia signaling pathways cancer genetics biological chemistry experimental medicine precision medicine molecular physiology tumor suppressors cell regulation cancer management drug targeting epidermal growth factor antitumor activity genome biology colorectal cancer hematological malignancies antibody screening lymphocyte development lymphoid neoplasia human lymphocytes melanoma blood cells cell physiology a431 cells apoptosis next-generation sequencing immunomodulation receptor (biochemistry) immune checkpoint inhibitors molecular regulation growth inhibition monoclonal antibody growth factors monoclonal antibodies cancer therapy anticancer therapy dna synthesis chimeric antibody growth factor alpha autonomous growth human natural cytotoxicity breast cancer cells

Notable Scholarly Works

Notable Federal Grants

Collaborators

Cooperative Effect of Oncogenic Met and Pik3Ca in an Hgf-Dominant Environment in Breast Cancer. Molecular Cancer Therapeutics (2019)

pathologycancer cellscell biologycancer biologymolecular cancercancer researchcancer lettertumor biologycarcinogenesisjama oncologymolecular cell biologytumor suppressorsbreast cancerbreast oncologyoncologyhgf-dominant environmentcancer geneticsoncogenescooperative effecttumor microenvironmentcancer discoverycancer growth

CORRECTION: A Feasibility Study of Returning Clinically Actionable Somatic Genomic Alterations Identified in a Research Laboratory. Oncotarget (2019)

Natalia Paez ArangoLauren BruscoKenna R. Mills ShawKen ChenAgda Karina EterovicVijaykumar HollaAmber JohnsonBeate LitzenburgerYekaterina B. KhotskayaNora SanchezAnn BaileyXiaofeng ZhengChacha HorombeScott KopetzCarol J. FarhangfarMark RoutbortRussell BroaddusElmer V. BernstamJohn MendelsohnGordon B. MillsFunda Meric-Bernstam

genomic medicinehealth sciencesgenomicsresearch laboratoryfeasibility study

Expanded Analysis of Secondary Germline Findings From Matched Tumor/Normal Sequencing Identifies Additional Clinically Significant Mutations. JCO Precision Oncology (2019)

Ecaterina Ileana DumbravaLauren BruscoMolly S. DanielsChetna WathooKenna R. ShawKaren H. LuXiaofeng ZhengLouise C. StrongJennifer LittonBanu K. ArunA. Karina EterovicMark J. RoutbortKeyur P. PatelYuan QiSarina A. Piha-PaulVivek SubbiahDavid S. HongJordi RodonScott KopetzJohn MendelsohnGordon B. MillsKen ChenFunda Meric-Bernstam

secondary germline findingssignificant mutationsoncologycancer genomics

Genomic and Transcriptomic Profiling Expands Precision Cancer Medicine: The Winther Trial. Nature Medicine (2019)

Jordi RodonJean-Charles SoriaRaanan BergerWilson H. MillerEitan RubinAleksandra KugelApostolia TsimberidouPierre SaintignyAliza AckersteinIrene BrañaYohann LoriotMohammad AfsharVincent MillerFanny WunderCatherine BressonJean-François MartiniJacques RaynaudJohn MendelsohnGerald BatistAmir OnnJosep TaberneroRichard L. SchilskyVladimir LazarJ. Jack LeeRazelle Kurzrock

clinical trialsbioinformaticsmedicinegenomicsprecision cancer medicinetranscriptomic profilingproteomicsoncologycancer genomicstranslational bioinformaticswinther trialmolecular biologygenome biologytranscriptomics technologymedicinal research

Precision Medicine Clinical Trials: Successes and Disappointments, Challenges and Opportunities – Lessons Learnt. Springer eBooks (2018)

Mark AbramovitzCasey WilliamsPradip K. DeNandini DeyScooter WillisBrandon YoungEleni AndreopoulouW. Fraser SymmansJason K. SicklickRichard L. SchilskyVladimir LazarCatherine BressonJohn MendelsohnRazelle KurzrockBrian Leyland-Jones

clinical trialsprecision medicinehealth sciences

Survival Outcomes by Tp53 Mutation Status in Metastatic Breast Cancer. JCO Precision Oncology (2018)

Funda Meric-BernstamXiaofeng ZhengMaryam ShariatiSenthil DamodaranChetna WathooLauren BruscoMehmet Esat DemirhanCoya TapiaAgda Karina EterovicReva K. BashoNaoto T. UenoFilip JankuAysegul SahinJordi RodonRussell BroaddusTae-Beom KimJohn MendelsohnKenna R. Mills ShawDebu TripathyGordon B. MillsKen Chen

metastatic breast cancersurvival outcomesgeneticscancer biologymolecular cancercancer researchcancer genomicsmetastasisprecision medicinepharmacologycancer treatmentbreast canceroncologycancer geneticscancer careoncogenesradiation oncologypersonalized medicinemedicinal research

WINTHER: An International Win Consortium Precision Medicine Trial Using Genomic and Transcriptomic Analysis in Patients With Advanced Malignancies.. Journal of Clinical Oncology (2018)

Jordi RodonJean-Charles SoriaRaanan BergerWilson H. MillerVladimir LazarEitan RubinApostolia Maria TsimberidouPierre SaintignyAliza AckersteinIrene BranaYohann LoriotMohammad AfsharVincent A. MillerFanny WunderCatherine BressonJean-Francois MartiniJohn MendelsohnRichard L. SchilskyJ. Jack LeeRazelle Kurzrock

clinical trialstranscriptomic analysishealth sciencesgenomicscancer researchoncologycancer genomicsprecision medicineclinical researchadvanced malignanciescancer caregenome analysis

Active Disclosure of Secondary Germline Findings to Deceased Research Participants’ Personal Representatives: Process and Outcomes. JCO Precision Oncology (2017)

Molly DanielsChetna WathooLauren BruscoKaren H. LuKenna ShawEcaterina E. Ileana DumbravaBanu ArunLouise StrongJennifer K. LittonKarina EterovicUgur AytacJohn MendelsohnGordon B. MillsKen ChenFunda Meric-Bernstam

secondary germline findingsoncologyresearch participants

ALK: A Tyrosine Kinase Target for Cancer Therapy. Molecular Case Studies (2017)

pharmacologymolecular cancercancer cellsdrug discoveryoncogenesreceptor tyrosine kinasesanti-cancer agentstyrosine kinase targetcell biologytherapeutic targets

Clinical Use of Precision Oncology Decision Support. JCO Precision Oncology (2017)

Amber JohnsonYekaterina B. KhotskayaLauren BruscoJia ZengVijaykumar HollaAnn M. BaileyBeate C. LitzenburgerNora S. SánchezMd Abu ShufeanSarina Piha-PaulVivek SubbiahDavid HongMark RoutbortRussell BroaddusKenna R. Mills ShawGordon B. MillsJohn MendelsohnFunda Meric-Bernstam

oncologyclinical use

1
2
3
4
5
24
10 / page

John Mendelsohn

Director

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Cancer Medicine

Department Of Palliative, Rehabilitation And Integrative Medicine

Department Of Neurosurgery

Department Of Pathology And Genomic Medicine

Department Of Thoracic-Head And Neck Medical Oncology

Division Of Cancer Medicine

The University of Texas MD Anderson Cancer Center

John Mendelsohn is currently serving as a Breast Surgical Oncology Director at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

John Mendelsohn

The University of Texas MD Anderson Cancer Center

Director

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Cooperative Effect of Oncogenic Met and Pik3Ca in an Hgf-Dominant Environment in Breast Cancer. Molecular Cancer Therapeutics (2019)

CORRECTION: A Feasibility Study of Returning Clinically Actionable Somatic Genomic Alterations Identified in a Research Laboratory. Oncotarget (2019)

genomic medicinehealth sciencesgenomicsresearch laboratoryfeasibility study

Expanded Analysis of Secondary Germline Findings From Matched Tumor/Normal Sequencing Identifies Additional Clinically Significant Mutations. JCO Precision Oncology (2019)

secondary germline findingssignificant mutationsoncologycancer genomics

Genomic and Transcriptomic Profiling Expands Precision Cancer Medicine: The Winther Trial. Nature Medicine (2019)

Precision Medicine Clinical Trials: Successes and Disappointments, Challenges and Opportunities – Lessons Learnt. Springer eBooks (2018)

clinical trialsprecision medicinehealth sciences

Survival Outcomes by Tp53 Mutation Status in Metastatic Breast Cancer. JCO Precision Oncology (2018)

WINTHER: An International Win Consortium Precision Medicine Trial Using Genomic and Transcriptomic Analysis in Patients With Advanced Malignancies.. Journal of Clinical Oncology (2018)

clinical trialstranscriptomic analysishealth sciencesgenomicscancer researchoncologycancer genomicsprecision medicineclinical researchadvanced malignanciescancer caregenome analysis

Active Disclosure of Secondary Germline Findings to Deceased Research Participants’ Personal Representatives: Process and Outcomes. JCO Precision Oncology (2017)

secondary germline findingsoncologyresearch participants

ALK: A Tyrosine Kinase Target for Cancer Therapy. Molecular Case Studies (2017)

pharmacologymolecular cancercancer cellsdrug discoveryoncogenesreceptor tyrosine kinasesanti-cancer agentstyrosine kinase targetcell biologytherapeutic targets

Clinical Use of Precision Oncology Decision Support. JCO Precision Oncology (2017)

oncologyclinical use

1
2
3
4
5
24
10 / page